Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
NCT06686771 is a phase 3 interventional trial sponsored by Canadian Cancer Trials Group. As of 21 Nov 2026, it is recruiting participants. It studies Non-small Cell Lung Cancer. The registry lists an enrollment of 320 participants at 75 sites in 2 countries. The registry lists a start date of 16 Dec 2025 and a primary completion date of 28 Feb 2030. 2 of its registered investigators have a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT06686771 |
| Status | Recruiting |
| Phase | Phase 3 |
| Study type | Interventional trial |
| Lead sponsor | Canadian Cancer Trials Group |
| Enrollment | 320 |
| Registered sites | 75 |
| Countries | 2 |
| Conditions | Non-small Cell Lung Cancer |
| Start | 16 Dec 2025 |
| Primary completion | 28 Feb 2030 |
| Study completion | 31 Dec 2030 |
| Last update posted | 14 Jul 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- C. Jillian Tsai
University Health Network Princess Margaret Hospital, Toronto, ON Canada
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
75 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital in Arizona
Phoenix
Nathan Y. YuRecruiting
- City of Hope Comprehensive Cancer Center
Duarte
Yufei LiuRecruiting - City of Hope at Irvine Lennar
Irvine
Yufei LiuRecruiting
- Saint Mary's Hospital and Regional Medical Center
Grand Junction
Lucas GilbrideRecruiting
- Ctca at Southeastern Regional Medical Center
Newnan
Lily ShakibniaRecruiting
- Saint Luke's Cancer Institute - Boise
Boise
Charles W. DrescherRecruiting - Saint Luke's Cancer Institute - Fruitland
Fruitland
Charles W. DrescherRecruiting - Saint Luke's Cancer Institute - Meridian
Meridian
Charles W. DrescherRecruiting - Saint Luke's Cancer Institute - Nampa
Nampa
Charles W. DrescherRecruiting
- Alton Memorial Hospital
Alton
Pamela SamsonRecruiting - Northwestern University
Chicago
Laila A. GharzaiRecruiting - Northwestern Medicine Cancer Center Kishwaukee
DeKalb
Laila A. GharzaiRecruiting - Decatur Memorial Hospital
Decatur
Bryan A. FallerRecruiting - Crossroads Cancer Center
Effingham
Bryan A. FallerRecruiting - Northwestern Medicine Cancer Center Delnor
Geneva
Laila A. GharzaiRecruiting - Northwestern Medicine Glenview Outpatient Center
Glenview
Laila A. GharzaiRecruiting - Northwestern Medicine Grayslake Outpatient Center
Grayslake
Laila A. GharzaiRecruiting - Northwestern Medicine Lake Forest Hospital
Lake Forest
Laila A. GharzaiRecruiting - Hshs Saint Elizabeth's Hospital
O'Fallon
Bryan A. FallerRecruiting - Northwestern Medicine Oak Brook
Oak Brook
Laila A. GharzaiRecruiting - Northwestern Medicine Orland Park
Orland Park
Laila A. GharzaiRecruiting - Memorial Hospital East
Shiloh
Pamela SamsonRecruiting - Northwestern Medicine Cancer Center Warrenville
Warrenville
Laila A. GharzaiRecruiting
- Ui Health Care Mission Cancer and Blood - Ankeny Clinic
Ankeny
Seema Harichand-HerdtRecruiting - Mercy Hospital
Cedar Rapids
Deborah W. WilburRecruiting - Oncology Associates at Mercy Medical Center
Cedar Rapids
Deborah W. WilburRecruiting - Ui Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive
Seema Harichand-HerdtRecruiting - Iowa Methodist Medical Center
Des Moines
Seema Harichand-HerdtRecruiting - Mercy Medical Center - Des Moines
Des Moines
Richard L. DemingRecruiting - Ui Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines
Seema Harichand-HerdtRecruiting - Ui Health Care Mission Cancer and Blood - Laurel Clinic
Des Moines
Seema Harichand-HerdtRecruiting - Ui Healthcare Mission Cancer and Blood - Pella
Pella
Seema Harichand-HerdtRecruiting - Ui Health Care Mission Cancer and Blood - Waukee Clinic
Waukee
Seema Harichand-HerdtRecruiting
- Miller-Dwan Hospital
Duluth
Bret E. FridayRecruiting - Mayo Clinic in Rochester
Rochester
Nathan Y. YuRecruiting - Coborn Cancer Center at Saint Cloud Hospital
Saint Cloud
Donald J. JurgensRecruiting
- Saint Francis Medical Center
Cape Girardeau
Bryan A. FallerRecruiting - Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters
Pamela SamsonRecruiting - Siteman Cancer Center at West County Hospital
Creve Coeur
Pamela SamsonRecruiting - Siteman Cancer Center at Christian Hospital
St Louis
Pamela SamsonRecruiting - Siteman Cancer Center-South County
St Louis
Pamela SamsonRecruiting - Washington University School of Medicine
St Louis
Pamela SamsonRecruiting
- Nebraska Medicine-Bellevue
Bellevue
Weining ZhenRecruiting - Nebraska Medicine-Village Pointe
Omaha
Weining ZhenRecruiting - University of Nebraska Medical Center
Omaha
Weining ZhenRecruiting
- Northwell Health/center for Advanced Medicine
Lake Success
A. G. WernickeRecruiting - Lenox Hill Hospital
New York
A. G. WernickeRecruiting - Manhattan Eye Ear and Throat Hospital
New York
A. G. WernickeRecruiting - Mount Sinai Chelsea
New York
Robert M. SamsteinRecruiting - Mount Sinai Hospital
New York
Robert M. SamsteinRecruiting - Mount Sinai West
New York
Robert M. SamsteinRecruiting - Queens Cancer Center
Rego Park
A. G. WernickeRecruiting - University of Rochester
Rochester
Philip SuteraRecruiting - Stony Brook University Medical Center
Stony Brook
Kartik M. ManiRecruiting - State University of New York Upstate Medical University
Syracuse
Michael D. MixRecruiting - Recruiting
- Recruiting
- Ohio State University Comprehensive Cancer Center
Columbus
Austin SimRecruiting
- University of Oklahoma Health Sciences Center
Oklahoma City
Tyler GunterRecruiting
- Geisinger Medical Center
Danville
Fiori AliteRecruiting - Penn State Milton S Hershey Medical Center
Hershey
Joseph A. MiccioRecruiting - Geisinger Medical Oncology-Lewisburg
Lewisburg
Fiori AliteRecruiting - Upmc Hillman Cancer Center at Rocco and Nancy Ortenzio Cancer Pavilion
Mechanicsburg
Neal McCallRecruiting - Thomas Jefferson University Hospital
Philadelphia
Cecilia JiangRecruiting - Upmc-Shadyside Hospital
Pittsburgh
Neal McCallRecruiting - Geisinger Wyoming Valley/henry Cancer Center
Wilkes-Barre
Fiori AliteRecruiting
- Vanderbilt University/ingram Cancer Center
Nashville
Evan C. OsmundsonRecruiting
- the Don and Sybil Harrington Cancer Center
Amarillo
Anita RavipatiRecruiting
- Vcu Massey Cancer Center at Stony Point
Richmond
Renato G. MartinsRecruiting - Vcu Massey Comprehensive Cancer Center
Richmond
Renato G. MartinsRecruiting
- Northwest Wisconsin Cancer Center
Ashland
Bret E. FridayRecruiting
- Cross Cancer Institute
Edmonton, Alberta
Alysa M. FairchildRecruiting - Cancercare Manitoba
Winnipeg, Manitoba
Vibhay PareekRecruiting - Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario
Michael TjongRecruiting - University Health Network-Princess Margaret Hospital
Toronto, Ontario
Chiaojung Jillian TsaiRecruiting
United States, by state
Outside the United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT06686771
Each answer restates registry values shown on this page.
What is NCT06686771?
NCT06686771 is a phase 3 interventional trial sponsored by Canadian Cancer Trials Group. It studies Non-small Cell Lung Cancer.
Is NCT06686771 recruiting?
As of 21 Nov 2026, it is recruiting participants. 75 of its 75 sites list their own status as recruiting.
Who leads NCT06686771?
The registry names C. Jillian Tsai (study chair, University Health Network Princess Margaret Hospital, Toronto, ON Canada) as the overall official.
Where does NCT06686771 run?
The registry lists 75 sites in 2 countries. Most sites are in these countries: United States (71) and Canada (4).
When is NCT06686771 expected to complete?
The registry lists a primary completion date of 28 Feb 2030 and a study completion date of 31 Dec 2030. The sponsor last updated the record on 14 Jul 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.